Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Delaware announces a plan to create a new legal form for AI-driven firms—the Autonomous AI Company (AIC)—to be triale...
U.S. Customs announced a 45-day, no-lawsuits refund program for tariffs, aiming to speed refunds to importers and red...
A new CBO forecast warns that social security’s trust fund could be empty by 2032, triggering automatic cuts that wou...
Six Republican senators warn Basel’s 1,250% risk weight could lock banks out of Bitcoin, a hurdle as Congress debates...
Sodexo is accelerating AI and robotics across its kitchen operations to cut labor costs, improve menu execution, and ...
A real-world scenario shows how misreporting income can unlock large public aid streams. Learn how programs gauge ear...
Two AI pioneers sit on the public markets' doorstep with wall-high expectations. This guide breaks down which giant—a...
A $1 million 401(K) balance can still bring big tax and Medicare costs. Here are five actionable moves to protect you...
Wednesday brought an outsized move for Sprinklr as earnings beat and optimism around CXM services spurred fresh buyin...
With yields in play and inflation cooling only slowly, a disciplined dividend portfolio that outlasts a 4% rule offer...
Spotify unveiled a long-term plan to hit 1 billion active users and sustain 20% operating margins by 2030, highlighti...